Video

Coverage From the 2012 NCONN Conference

Author(s):

OncLive presents live coverage from the 2012 NCONN Changing the Face of Cancer Care Conference, held at the Gaylord Opryland Hotel from October 4th to 6th, in Nashville, TN.

OncLive presents live coverage from the 2012 National Coalition of Oncology Nurse Navigators' (NCONN) annual conference, Changing the Face of Cancer Care, held at the Gaylord Opryland Hotel from October 4th to 6th, in Nashville, Tennessee.

Presentations and breakout sessions at the NCONN meeting feature expert insight into the optimal multidisciplinary management of patients with cancer.

The meeting seeks to address the real-time needs of oncology nurses, oncology nurse navigators, clinical nurse specialists, social workers, community healthcare workers, and patient navigators.

OncLive’s conference coverage features video interviews with leading specialists and articles highlighting the top presentations from the meeting.

For more information on NCONN, visit nconn.org.

Not signed up to receive OncLive emails? Make an account today to make sure that you don't miss updates from our conference coverage. Register now!

<<<

View coverage from the 2012 NCONN Conference

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Sheldon M. Feldman, MD
Rita Mukhtar, MD
Lajos Pusztai, MD, DPhil
Hope S. Rugo, MD
Karl Semaan, MD, MSc
Bradley McGregor, MD, discusses findings from a phase 1b study of abemaciclib  in clear cell renal cell carcinoma.